Jack Zamora - Nov 11, 2022 Form 3 Insider Report for Vitro Biopharma, Inc. (NONE)

Role
Director, 10%+ Owner
Signature
/s/ Jack Zamora
Stock symbol
NONE
Transactions as of
Nov 11, 2022
Transactions value $
$0
Form type
3
Date filed
11/17/2022, 11:45 AM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NONE Common Stock 34.2M Nov 11, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NONE Employee Stock Option (Right to Buy) Nov 11, 2022 Common Stock 666K $0.29 Direct F1
holding NONE Employee Stock Option (Right to Buy) Nov 11, 2022 Common Stock 1M $0.50 Direct
holding NONE Warrant (Right to Buy) Nov 11, 2022 Common Stock 250K $0.50 Direct
holding NONE Warrant (Right to Buy) Nov 11, 2022 Common Stock 250K $1.00 Direct
holding NONE Warrant (Right to Buy) Nov 11, 2022 Common Stock 180K $0.50 Direct
holding NONE Warrant (Right to Buy) Nov 11, 2022 Common Stock 180K $1.00 Direct
holding NONE Warrant (Right to Buy) Nov 11, 2022 Common Stock 173K $0.50 Direct
holding NONE Warrant (Right to Buy) Nov 11, 2022 Common Stock 173K $1.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option became exercisable as to (i) 333,000 shares on April 9, 2021 and (ii) 333,000 shares on April 9, 2022.